Get started
Author

Manfred Hauben

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration
2024 · Michele Fusaroli, Francesco Salvo, et al. · Drug Safety · 366
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement
2024 · Michele Fusaroli, Francesco Salvo, et al. · Drug Safety · 298
PDF
The role of data mining in pharmacovigilance
2005 · Manfred Hauben, David Madigan, et al. · Expert Opinion on Drug Safety · 277
Perspectives on the Use of Data Mining in Pharmacovigilance
2005 · June Almenoff, Joseph M Tonning, et al. · Drug Safety · 251
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
2020 · Philip Mease, Christina Charles-Schoeman, et al. · Annals of the Rheumatic Diseases · 218
PDF
Anecdotes that provide definitive evidence
2006 · Jeffrey K Aronson, Manfred Hauben · BMJ · 184
Quantitative Methods in Pharmacovigilance
2003 · Manfred Hauben, Xiaofeng Zhou · Drug Safety · 180
Defining ‘Signal’ and its Subtypes in Pharmacovigilance Based on a Systematic Review of Previous Definitions
2009 · Manfred Hauben, Jeffrey K. Aronson · Drug Safety · 172
Decision support methods for the detection of adverse events in post-marketing data
2009 · M. Hauben, A. Bate · Drug Discovery Today · 163
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods
2010 · Jessica A. Reese, Xiaoning Li, et al. · Blood · 147
Data mining for signals in spontaneous reporting databases: proceed with caution
2006 · Wendy P. Stephenson, Manfred Hauben · Pharmacoepidemiology and Drug Safety · 135
Gold Standards in Pharmacovigilance
2007 · Manfred Hauben, Jeffrey K Aronson · Drug Safety · 86
Cyclosporine Neurotoxicity
1996 · Manfred Hauben · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 85
???Extreme Duplication??? in the US FDA Adverse Events Reporting System Database
2007 · Manfred Hauben, Lester Reich, et al. · Drug Safety · 79
A Brief Primer on Automated Signal Detection
2003 · Manfred Hauben · Annals of Pharmacotherapy · 78
Paradoxical and Bidirectional Drug Effects
2012 · Silas W. Smith, Manfred Hauben, et al. · Drug Safety · 72
An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database
2010 · Hsin-wei Wang, Alan M. Hochberg, et al. · Drug Safety · 72
Influence of the MedDRA® hierarchy on pharmacovigilance data mining results
2009 · Ronald K. Pearson, Manfred Hauben, et al. · International Journal of Medical Informatics · 71
Data Mining in Pharmacovigilance
2005 · Manfred Hauben, Vaishali Patadia, et al. · Drug Safety · 64
Safety Related Drug-Labelling Changes
2004 · Manfred Hauben, Lester Reich · Drug Safety · 59
A Systematic Review of Artificial Intelligence and Machine Learning Applications to Inflammatory Bowel Disease, with Practical Guidelines for Interpretation
2022 · Imogen S Stafford, Mark M Gosink, et al. · Inflammatory Bowel Diseases · 56
Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases
2013 · Francois Maignen, Manfred Hauben, et al. · Pharmacoepidemiology and Drug Safety · 56
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach
2023 · Valentina Giunchi, Michele Fusaroli, et al. · Drug Safety · 52
PDF
Artificial Intelligence and Data Mining for the Pharmacovigilance of Drug–Drug Interactions
2023 · Manfred Hauben · Clinical Therapeutics · 51
PDF
Drug‐induced pancreatitis: lessons in data mining
2004 · Manfred Hauben, Lester Reich · British Journal of Clinical Pharmacology · 49
PDF
Works count: 159
Citation count: 4,782
H-index: 35
I10-index: 80
Year
Topic
Type